Sensorial Evaluation of Eslicarbazepine Acetate Oral Suspension

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-C-002-Tuesday
• By: ALMEIDA, Hugo (Bial - Portela & Cª, S.A., R&D Department - Pharmaceutical Development, Coronado (S. Romão e S. Mamede), Portugal)
• Co-author(s): Hugo Miguel Almeida: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
  Teofilo Vasconcelos: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
  Ricardo Lima: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
  Patrício Soares-da-Silva: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
  
• Abstract:

  Backgrounds

  Sensorial evaluation of an oral suspension is a critical parameter in the development of this oral dosage form.

  Aims

  To describe the study conducted to assess palatability and acceptability by adult humans of eslicarbazepine acetate oral suspension.

  Methods

  Two adult panels were submitted to the study: one in Europe (7 males + 7 females)

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login